| Financial Year |
March 31 2023 |
| Monetary Funds |
487,933,765.06 |
| Held-for-trading Financial Assets |
30,878,813.45 |
| Notes Receivable |
-- |
| Accounts Receivable |
360,210,716.47 |
| Advances to Suppliers |
55,770,426.80 |
| Other Receivables |
22,939,545.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
234,663,996.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,582,001.06 |
| Total Current Assets |
1,341,900,250.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
114,691,584.83 |
| Investment Properties |
60,394,987.07 |
| Fixed Assetes |
493,376,279.76 |
| Under-construction Projects |
389,911,745.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,727,890.88 |
| R&D expenses |
34,154,845.10 |
| Goodwill |
341,661,956.48 |
| Long-Term Deferred and Prepaid Expenses |
7,502,207.26 |
| Deferred Income Tax Assets |
52,433,010.85 |
| Other Non-Current Assets |
761,121,180.06 |
| Sub-Total of Non-Current Assets |
2,451,507,020.46 |
| Total Assets |
3,793,407,270.55 |
| Short-Term Loans |
16,426,033.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
104,465,814.88 |
| Accounts Payable |
107,475,258.83 |
| Accounts Received In Advance |
575,363.97 |
| Employee Compensation Payable |
8,908,015.49 |
| Taxes Payable |
77,667,455.79 |
| Interest Payable |
-- |
| Dividend Payable |
452,499.84 |
| Other payables |
116,328,186.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,426,325.41 |
| Other Current Liabilities |
1,445,837.54 |
| Sub-Total of Current Liabilities |
465,536,816.67 |
| Long-term Loans |
47,631,389.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
222,687.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,256,946.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
91,532,916.48 |
| Total Liabilities |
557,069,733.15 |
| Paid-In Capital(Or Share Stock) |
323,905,337.00 |
| Capital Surplus |
2,079,376,673.11 |
| Surplus Reserve |
81,438,137.21 |
| LESS:Treasury Stock |
86,355,464.57 |
| Undistributed Profits |
852,241,844.13 |
| Minority Stockholder's Interest |
-20,387,977.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,256,725,515.29 |
| Owner's Equity（Stockholder's Equity） |
3,236,337,537.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,793,407,270.55 |
